Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients
出版年份 2014 全文链接
标题
Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF OBESITY
Volume 39, Issue 1, Pages 121-129
出版商
Springer Nature
发表日期
2014-05-12
DOI
10.1038/ijo.2014.76
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Role of FGF19 induced FGFR4 activation in the regulation of glucose homeostasis
- (2016) Xinle Wu et al. Aging-US
- The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes
- (2013) Gregory Gaich et al. Cell Metabolism
- A Role for Fibroblast Growth Factor 19 and Bile Acids in Diabetes Remission After Roux-en-Y Gastric Bypass
- (2013) G. S. Gerhard et al. DIABETES CARE
- Increased fibroblast growth factor 21 expression in high-fat diet-sensitive non-human primates (Macaca mulatta)
- (2013) E B Nygaard et al. INTERNATIONAL JOURNAL OF OBESITY
- Serum fibroblast growth factor 21 in human obesity: regulation by insulin infusion and relationship with glucose and lipid oxidation
- (2013) M Strączkowski et al. INTERNATIONAL JOURNAL OF OBESITY
- Carbohydrate Feeding Dissociates the Postprandial FGF19 Response From Circulating Bile Acid Levels in Humans
- (2013) Gregory J. Morton et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fibroblast growth factor-21 is expressed in neonatal and pheochromocytoma-induced adult human brown adipose tissue
- (2013) Elayne Hondares et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- βKlotho Is Required for Fibroblast Growth Factor 21 Effects on Growth and Metabolism
- (2012) Xunshan Ding et al. Cell Metabolism
- Fibroblast Growth Factor 21 Predicts the Metabolic Syndrome and Type 2 Diabetes in Caucasians
- (2012) T. Bobbert et al. DIABETES CARE
- TNF-α Represses β-Klotho Expression and Impairs FGF21 Action in Adipose Cells: Involvement of JNK1 in the FGF21 Pathway
- (2012) Julieta Díaz-Delfín et al. ENDOCRINOLOGY
- Reduced Levels of Serum FGF19 and Impaired Expression of Receptors for Endocrine FGFs in Adipose Tissue From HIV-Infected Patients
- (2012) José M. Gallego-Escuredo et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Fibroblast Growth Factor 21 (FGF-21) and Its Relation to Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver in Children: A Longitudinal Analysis
- (2012) Thomas Reinehr et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Increased Responses to the Actions of Fibroblast Growth Factor 21 on Energy Balance and Body Weight in a Seasonal Model of Adiposity
- (2012) M. Murphy et al. JOURNAL OF NEUROENDOCRINOLOGY
- Aberrantly elevated microRNA-34a in obesity attenuates hepatic responses to FGF19 by targeting a membrane coreceptor -Klotho
- (2012) T. Fu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue
- (2012) Andrew C. Adams et al. Molecular Metabolism
- High Plasma Level of Fibroblast Growth Factor 21 Is an Independent Predictor of Type 2 Diabetes: A 5.4-year population-based prospective study in Chinese subjects
- (2011) C. Chen et al. DIABETES CARE
- Serum FGF21 levels are increased in newly diagnosed type 2 diabetes with nonalcoholic fatty liver disease and associated with hsCRP levels independently
- (2011) Xuesong Li et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity
- (2011) Fredirick L. Mashili et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Integrated Regulation of Hepatic Metabolism by Fibroblast Growth Factor 21 (FGF21)in Vivo
- (2011) ffolliott M. Fisher et al. ENDOCRINOLOGY
- Lack of Overt FGF21 Resistance in Two Mouse Models of Obesity and Insulin Resistance
- (2011) Clarence Hale et al. ENDOCRINOLOGY
- Vitamin A decreases pre-receptor amplification of glucocorticoids in obesity: study on the effect of vitamin A on 11beta-hydroxysteroid dehydrogenase type 1 activity in liver and visceral fat of WNIN/Ob obese rats
- (2011) Vara Prasad SS Sakamuri et al. Nutrition Journal
- FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis
- (2011) S. Kir et al. SCIENCE
- Serum FGF21 levels are elevated in association with lipodystrophy, insulin resistance and biomarkers of liver injury in HIV-1-infected patients
- (2010) Pere Domingo et al. AIDS
- Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
- (2010) f. M. Fisher et al. DIABETES
- Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
- (2010) Jody Dushay et al. GASTROENTEROLOGY
- Relation between fibroblast growth factor–21, adiposity, metabolism, and weight reduction
- (2010) Knut Mai et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- FGF21 reloaded: challenges of a rapidly growing field
- (2010) Alexei Kharitonenkov et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Free Fatty Acids Link Metabolism and Regulation of the Insulin-Sensitizing Fibroblast Growth Factor-21
- (2009) K. Mai et al. DIABETES
- Circulating Fibroblast Growth Factor-21 Is Elevated in Impaired Glucose Tolerance and Type 2 Diabetes and Correlates With Muscle and Hepatic Insulin Resistance
- (2009) A. O. Chavez et al. DIABETES CARE
- Fibroblast Growth Factor-19, a Novel Factor That Inhibits Hepatic Fatty Acid Synthesis
- (2009) Sushant Bhatnagar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Selective activation of FGFR4 by an FGF19 variant does not improve glucose metabolism in ob/ob mice
- (2009) X. Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- FGF21 induces PGC-1 and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response
- (2009) M. J. Potthoff et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans
- (2008) X. Zhang et al. DIABETES
- Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice
- (2008) J. Xu et al. DIABETES
- Fibroblast Growth Factor 21 Corrects Obesity in Mice
- (2008) Tamer Coskun et al. ENDOCRINOLOGY
- βKlotho Is Required for Fibroblast Growth Factor (FGF) 21 Signaling through FGF Receptor (FGFR) 1c and FGFR3c
- (2008) Masashi Suzuki et al. MOLECULAR ENDOCRINOLOGY
- Mini-Review: Endocrine Actions of Fibroblast Growth Factor 19
- (2008) Stacey Jones MOLECULAR PHARMACEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now